期刊文献+

右美托咪定复合瑞芬太尼用于脑功能区胶质瘤切除术中唤醒麻醉的临床观察 被引量:21

Dexmedetomidine combined with remifentanil in intraoperative wake-up test in functional neurosurgery
下载PDF
导出
摘要 目的:观察右美托咪定复合瑞芬太尼在神经外科脑功能区胶质瘤术唤醒麻醉中的效果。方法:选择40例需行脑功能区胶质瘤切除的患者,(ASA)Ⅰ-Ⅱ级,随机分为右美托咪定复合瑞芬太尼观察组(A组)(n=20)和丙泊酚复合瑞芬太尼对照组(B组)(n=20),并应用两组方法行脑功能区胶质瘤切除手术术中唤醒麻醉。记录两组在术前(T0)及唤醒期间(T1)血压、心率、脉搏氧饱和度和呼吸频率的变化、唤醒时间、呛咳次数、体动次数。术后2d、7d、14d随访病人,了解患者精神伤害情况。结果:A、B两组术前血压、心率和呼吸抑制情况比较无差异(P>0.05),唤醒期间A组SBP、MAP、HR和呼吸抑制情况显著低于B组,有统计学意义(P<0.05),唤醒时间A组较短,明显短于B组(P<0.05),且呛咳次数及体动次数A组低于B组(P<0.05)。精神伤害的发生率两组无差异(P>0.05)。结论:右美托咪定复合瑞芬太尼应用于脑功能区胶质瘤切除术术中唤醒麻醉对病人血流动力学影响较小,病人苏醒快,不良事件发生率低,较丙泊酚复合瑞芬太尼有一定优势。 Objective:To observe the effect of dexmedetomidine combined with remifentanil in intraoperative wake - up test in functional neurosurgery. Methods: Forty neurosurgery patients, ASA I or , requiring intraoperative wake - up test during functional neurosurgery were randomly divided into two groups, 20 for each group. Wake - up test for location of brain domain was completeted using dexmedetomidine combined with remifentanil group (group A, n = 20 ) or propofol combined with remifentanil(group B, n = 20). The change of BP, HR, SPO2 and RR in preoperative(To ) and awakening( T1 ) ,wake -up time ,wake -up quality, bucking and agitation were recorded. Visit the patients at the time of 2 day,7 day and 14 day after the operation, and acquire the mental injury condition. Results:There was no significant difference in blood pressure, heart rate and respiratory depression in preoperative ( P 〉 0.05 ). During the awakening, compared with group B, the SBP, MAP, HR and respiratory depression in group A was deceased( P 〈 0.05) ; Patients in group A required less time for wake - up, had higher wake - up quality and had less incidences of bucking and agitation compared with group B(P 〈0.05). There was no significant difference in mental injury condi- tion in both group(P 〉 0.05 ). Conclusion:Compared with propofol combined with remifentanil, intraoperative wake -up test in functional neurosurgery has more advantages, with dexmedetomidine combined with remifentanil because of stable haemodynamics ,high waking quality and adverse events.
出处 《现代肿瘤医学》 CAS 2014年第4期914-917,共4页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81271343)
关键词 右美托咪定 瑞芬太尼 丙泊酚 胶质瘤 术中唤醒 dexmedetomidine remifentanil propofol glioma wake - up test
  • 相关文献

参考文献13

  • 1Sarang A,Dinsmore J.Anaesthesia for awake craniotomy-evolution of a technique that facilitates awake neurological testing[J].Br J Anaesth,2003,90(2):161-165.
  • 2李晓军,何林.右美托咪定对脊柱矫形术中唤醒试验效果的影响研究[J].中国询证医学杂志,2013,13(6):692-695.
  • 3Olsen KS.The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours[J].Eur J Anaesthesiol,2008,25 (8):662-669.
  • 4施冲,吴群林,刘中华,徐波,于冬男,戴建强,郄文斌.脑功能区手术唤醒麻醉与清醒程度的研究[J].中国微侵袭神经外科杂志,2005,10(11):497-498. 被引量:27
  • 5王伟民,李天栋,蒋小星,等.术中全麻唤醒下定位切除脑功能区病变[J].中国侵袭神经外科杂志,2003,8(6):245-249.
  • 6Gignac E,Manninen PH,Gelb AW.Comparison of fentanyl,sufentanil and alfentanil during awake craniotomy for epilepsy[J].Can J Anaesth,1993,40(5 Pt 1):421-424.
  • 7Manninen PH,Balki M,Lukitto K,et al.Patient satisfaction with awake craniotomy for tumor surgery:a comparison of remifentanil and fentanyl in conjunction with propofol[J].Anesth Analg,2006,102(1):237-242.
  • 8Ard JL Jr,Bekker AY,Doyle WK.Dexmedetomidine in awake craniotomy:a technical note[J].Surg Neurol,2005,63 (2):114-117.
  • 9Ramadhyani U,Park JL,Carollo DS,et al.Dexmedetomidine clinical application as an adjunct for intravenous regional anethesia[J].Anesthesiol Clin,2010,28 (4):709-722.
  • 10郑娜,尹世平,欧阳卫东.右美托咪定在脊柱侧凸矫形术中的应用[J].南昌大学学报(医学版),2012,52(2):55-57. 被引量:5

二级参考文献11

  • 1吴群林,施冲,刘中华,徐波,于冬男,戴建强,郗文彬,张兴安.丙泊酚复合瑞芬太尼在脑功能区手术唤醒麻醉的应用研究[J].实用医学杂志,2005,21(20):2329-2331. 被引量:5
  • 2Fukaya C, Katayama Y, Yoshino A, et al. Intraoperative wake-up procedure with propofol and laryngeal mask for optimal excision of brain tumour in eloquent areas [J]. J Clin Neurosci, 2001; 8(3): 253-255.
  • 3Sarang A, Dinsmore J. Anaesthesia for awake craniotomyevolution of a technique that facilitates awake neurological testing [J]. Br J Anaesth, 2003; 90(2): 161-165.
  • 4Sinclair M D. A review of the physiological effects of αlpha2-agonists related to the clinical use of medetomidine in small animal practice[J].Canadian Veterinary Journal-Revue Veterinaire Canadienne,2003,(11):885-897.
  • 5Baiwa S J,Arora V,Singh A. Comparative evaluation of dexmedetomidine and fentanyl for epidural analgesia in lower limb orthopedic surgeries[J].Saudi J Anaesth,2011,(04):365-370.
  • 6Miller R D. Miller's Anesthesia[M].New York:Churchill livingstone,2005.2418-2419.
  • 7Carollo D S,Nossaman B D,Ramadhyani U. Dexmedetomidine:a review of clinical applications[J].Current Opinion in Anaesthesiology,2008,(04):457-461.
  • 8Nelson L E,Lu J,Guo T. The α2-adrenoceptor agonist dexmedetomitine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003,(02):428-436.doi:10.1097/00000542-200302000-00024.
  • 9Correa Sales C,Rabin B C,Maze M. A hypnotic response to dexmedetomidine,an αlpha-2 agonist,is mediated in the locus corruleus in rats[J].Anesthesiology,1992,(06):948-952.
  • 10Bicer C,Esmaoglu A,Akin A. Dexmedetomidine and meperidine prevent postanaesthetic shivering[J].European Journal of Anaesthesiology,2006,(02):149-153.doi:10.1017/S0265021505002061.

共引文献30

同被引文献189

引证文献21

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部